Carsten Denkert
Philipps University of Marburg(DE)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Advanced Breast Cancer Therapies
Most-Cited Works
- → An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients(2009)4,325 cited
- → The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014(2014)3,065 cited
- → Pembrolizumab for Early Triple-Negative Breast Cancer(2020)2,944 cited
- → Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes(2012)2,632 cited
- → Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy(2017)2,068 cited
- → Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer(2009)1,771 cited
- → Breast cancer(2021)1,552 cited
- → Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization(2012)1,262 cited
- → Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial(2014)1,257 cited
- → De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017(2017)1,245 cited